<SEC-DOCUMENT>0001193125-21-270077-index.html : 20210910
<SEC-HEADER>0001193125-21-270077.hdr.sgml : 20210910
<ACCEPTANCE-DATETIME>20210910164933
ACCESSION NUMBER:		0001193125-21-270077
CONFORMED SUBMISSION TYPE:	S-8
PUBLIC DOCUMENT COUNT:		6
FILED AS OF DATE:		20210910
DATE AS OF CHANGE:		20210910
EFFECTIVENESS DATE:		20210910

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			IN8BIO, INC.
		CENTRAL INDEX KEY:			0001740279
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		IRS NUMBER:				825462585
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		S-8
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-259458
		FILM NUMBER:		211247578

	BUSINESS ADDRESS:	
		STREET 1:		79 MADISON AVENUE, 2ND FLOOR
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10016
		BUSINESS PHONE:		(646) 600-6438

	MAIL ADDRESS:	
		STREET 1:		79 MADISON AVENUE, 2ND FLOOR
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10016

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Incysus Therapeutics, Inc.
		DATE OF NAME CHANGE:	20180510
</SEC-HEADER>
<DOCUMENT>
<TYPE>S-8
<SEQUENCE>1
<FILENAME>d216810ds8.htm
<DESCRIPTION>S-8
<TEXT>
Document 1 - file: d216810ds8.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.6
<SEQUENCE>2
<FILENAME>d216810dex46.htm
<DESCRIPTION>EX-4.6
<TEXT>
Document 2 - file: d216810dex46.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.9
<SEQUENCE>3
<FILENAME>d216810dex49.htm
<DESCRIPTION>EX-4.9
<TEXT>
Document 3 - file: d216810dex49.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.1
<SEQUENCE>4
<FILENAME>d216810dex51.htm
<DESCRIPTION>EX-5.1
<TEXT>
Document 4 - file: d216810dex51.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>5
<FILENAME>d216810dex231.htm
<DESCRIPTION>EX-23.1
<TEXT>
Document 5 - file: d216810dex231.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>g216810g0908053042646.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 6 - file: g216810g0908053042646.jpg

</DOCUMENT>
</SEC-DOCUMENT>